First clinical trial of vosoritide for children with hypochondroplasia shows increased growth
WASHINGTON, April 11, 2024 (GLOBE NEWSWIRE) -- Vosoritide’s first global phase 2 study showed an average increased growth rate of..
GlobeNewswire
WASHINGTON, April 11, 2024 (GLOBE NEWSWIRE) -- Vosoritide’s first global phase 2 study showed an average increased growth rate of..